• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Matthew Perrone

    Matthew Perrone

    FILE - In this Tuesday, Dec. 21, 2004, file photo, several Aleve tablets appear in front of bottles of the pain reliever, in Boston.  Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains. (AP Photo/Steven Senne, File)
    Business

    FDA reconsiders heart safety of common pain pills

    Matthew Perrone -
    February 10, 2014 9:36 pm
    0
    Pharma data play larger role in Olympic drug tests
    Business

    Pharma data play larger role in Olympic drug tests

    Matthew Perrone -
    February 7, 2014 11:10 pm
    0
    This undated image provided by Given Imaging, shows  the new bite-size camera to help screen patients who have trouble with colonoscopies. The Food and Drug Administration cleared the device for patients who have had trouble with the cringe-inducing colonoscopy procedure, which involves probing the large intestine with a tiny camera embedded in a four-foot long, flexible tube. (AP Photo/Given Imaging)
    Business

    FDA approves pill camera to screen colon

    Matthew Perrone -
    February 3, 2014 11:09 pm
    0
    FDA reviews safety of testosterone therapy for men
    Business

    FDA reviews safety of testosterone therapy for men

    Matthew Perrone -
    January 31, 2014 11:24 pm
    0
    FDA: Aleve may be safer on heart than rival drugs
    Business

    FDA: Aleve may be safer on heart than rival drugs

    Matthew Perrone -
    January 28, 2014 10:12 pm
    0
    FDA approves diabetes drug with new approach
    News

    FDA approves diabetes drug with new approach

    Matthew Perrone -
    January 8, 2014 6:01 pm
    0
    Feds crack down on 4 bogus weight loss aids
    News

    Feds crack down on 4 bogus weight loss aids

    Matthew Perrone -
    January 7, 2014 8:40 pm
    0
    New drug approvals from FDA declined in 2013
    News

    New drug approvals from FDA declined in 2013

    Matthew Perrone -
    January 2, 2014 4:05 pm
    0
    FILE - This Tuesday, April 30, 2013, file photo, shows Dawn Ultra antibacterial soap in a kitchen in Chicago.  The Food and Drug Administration says Monday, Dec. 16, 2013, there is no evidence that antibacterial chemicals used in liquid soaps and washes help prevent the spread of germs, and there is some evidence they may pose health risks. (AP Photo/Kiichiro Sato)
    News

    FDA: Anti-bacterial soaps may not curb bacteria

    Matthew Perrone -
    December 16, 2013 11:07 pm
    0
    In this  Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. Sprout Pharmaceuticals said Wednesday, Dec. 11, 2013, it has reached an impasse with the Food and Drug Administration over its drug, flibanserin. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. (AP Photo/Allen G. Breed)
    News

    Female libido drug remains in limbo

    Matthew Perrone -
    December 11, 2013 7:33 pm
    0
    1...678...16Page 7 of 16
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter